These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 1378877)
21. Detection of hepatitis C virus by polym erase chain reaction in haemodialysed patients in relationship to anti-HCV status. Bouchardeau F; Chauveau P; Le Marrec N; Girault A; Zins B; Couroucé AM Res Virol; 1993; 144(3):233-42. PubMed ID: 8395076 [TBL] [Abstract][Full Text] [Related]
22. New-generation RIBA hepatitis C strip immunoblot assays. Polito AJ; DiNello RK; Quan S; Andrews W; Rose J; Lee F; Nelles M; Lee S Beitr Infusionsther; 1992; 30():17-33. PubMed ID: 1284698 [TBL] [Abstract][Full Text] [Related]
23. [Anti-HCV in patients without risk factors for hepatitis C. Prospective study in 200 patients]. Albornoz A; Esaa R; Rodríguez de Leon L; Mujica C G E N; 1993; 47(3):136-8. PubMed ID: 7509301 [TBL] [Abstract][Full Text] [Related]
24. Human immunodeficiency virus infection as risk factor for mother-to-child hepatitis C virus transmission; persistence of anti-hepatitis C virus in children is associated with the mother's anti-hepatitis C virus immunoblotting pattern. Manzini P; Saracco G; Cerchier A; Riva C; Musso A; Ricotti E; Palomba E; Scolfaro C; Verme G; Bonino F Hepatology; 1995 Feb; 21(2):328-32. PubMed ID: 7843701 [TBL] [Abstract][Full Text] [Related]
25. Antibody responses to the hepatitis C virus E2 protein: relationship to viraemia and prevalence in anti-HCV seronegative subjects. Cerino A; Bissolati M; Cividini A; Nicosia A; Esumi M; Hayashi N; Mizuno K; Slobbe R; Oudshoorn P; Silini E; Asti M; Mondelli MU J Med Virol; 1997 Jan; 51(1):1-5. PubMed ID: 8986942 [TBL] [Abstract][Full Text] [Related]
26. Anti-hepatitis C virus antibodies and hepatitis C virus viraemia in haemodialysis patients. Picciotto A; Varagona G; Gurreri G; Fiorini F; Sofia A; Coviello DA; Bonanni P; Icardi GC; Valle F; Celle G Nephrol Dial Transplant; 1993; 8(10):1115-7. PubMed ID: 8272226 [TBL] [Abstract][Full Text] [Related]
27. Frequency and chronology of occurrence of anti-HCV in non-A non-B post-transfusional hepatitis. Barcena R; Martín-de-Argila C; Ulibarrena C; Erdozain JC; Gil Grande LA; Mateos M Rev Esp Enferm Dig; 1993 Oct; 84(4):245-8, 241-4. PubMed ID: 8292436 [TBL] [Abstract][Full Text] [Related]
28. Analysis of ELISA hepatitis C virus-positive blood donors population by polymerase chain reaction and recombinant immunoblot assay (RIBA). Comparison of second and third generation RIBA. Chicheportiche C; Cantaloube JF; Biagini P; Aumont P; Donnadieu F; Escher J; Larabi F; Zepitelli JP Acta Virol; 1993; 37(2-3):123-31. PubMed ID: 7692714 [TBL] [Abstract][Full Text] [Related]
29. Temporal relationships of hepatitis C virus RNA and antibody responses following experimental infection of chimpanzees. Beach MJ; Meeks EL; Mimms LT; Vallari D; DuCharme L; Spelbring J; Taskar S; Schleicher JB; Krawczynski K; Bradley DW J Med Virol; 1992 Mar; 36(3):226-37. PubMed ID: 1373438 [TBL] [Abstract][Full Text] [Related]
30. Serological response and detection of viraemia in acute hepatitis C virus infection. Dourakis S; Brown J; Kumar U; Karayiannis P; Kernoff P; Chiba J; Ohba H; Miyamura T; Saito I; Monjardino J J Hepatol; 1992 Mar; 14(2-3):370-6. PubMed ID: 1380025 [TBL] [Abstract][Full Text] [Related]
31. Immune response to epitopes of hepatitis C virus (HCV) structural proteins in HCV-infected humans and chimpanzees. Wang YF; Brotman B; Andrus L; Prince AM J Infect Dis; 1996 Apr; 173(4):808-21. PubMed ID: 8603958 [TBL] [Abstract][Full Text] [Related]
32. Hepatitis C virus replication during acute infection in the chimpanzee. Shindo M; Di Bisceglie AM; Biswas R; Mihalik K; Feinstone SM J Infect Dis; 1992 Aug; 166(2):424-7. PubMed ID: 1321863 [TBL] [Abstract][Full Text] [Related]
33. Demonstration of viraemia patterns in haemophiliacs treated with hepatitis-C-virus-contaminated factor VIII concentrates. Garson JA; Tuke PW; Makris M; Briggs M; Machin SJ; Preston FE; Tedder RS Lancet; 1990 Oct; 336(8722):1022-5. PubMed ID: 1977017 [TBL] [Abstract][Full Text] [Related]
34. Lack of protective immunity against reinfection with hepatitis C virus. Farci P; Alter HJ; Govindarajan S; Wong DC; Engle R; Lesniewski RR; Mushahwar IK; Desai SM; Miller RH; Ogata N Science; 1992 Oct; 258(5079):135-40. PubMed ID: 1279801 [TBL] [Abstract][Full Text] [Related]
35. Evaluation of a chimpanzee colony for antibodies to hepatitis C virus. Lanford RE; Notvall L; Barbosa LH; Eichberg JW J Med Virol; 1991 Jul; 34(3):148-53. PubMed ID: 1717646 [TBL] [Abstract][Full Text] [Related]
36. The effect on the safety of intravenous immunoglobulin of testing plasma for antibody to hepatitis C. Biswas RM; Nedjar S; Wilson LT; Mitchell FD; Snoy PJ; Finlayson JS; Tankersley DL Transfusion; 1994 Feb; 34(2):100-4. PubMed ID: 7508642 [TBL] [Abstract][Full Text] [Related]
38. Hepatitis C viraemia and antibody to core epitopes in anti-HCV ELISA negative blood donors. Ferroni P; Gasparini V; Zaninetti M; Colzani D; Mascolo G Eur J Epidemiol; 1994 Oct; 10(5):649-50. PubMed ID: 7532137 [No Abstract] [Full Text] [Related]
39. Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization. Farci P; Alter HJ; Wong DC; Miller RH; Govindarajan S; Engle R; Shapiro M; Purcell RH Proc Natl Acad Sci U S A; 1994 Aug; 91(16):7792-6. PubMed ID: 7519785 [TBL] [Abstract][Full Text] [Related]
40. Hepatitis C virus (HCV) specific immune responses in anti-HCV positive patients without hepatitis C viraemia. Cramp ME; Carucci P; Rossol S; Chokshi S; Maertens G; Williams R; Naoumov NV Gut; 1999 Mar; 44(3):424-9. PubMed ID: 10026332 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]